Keyphrases
Competitive Inhibition
100%
Cell Function
100%
Liver Fibrosis
100%
Leptin
100%
Stellate Cells
100%
Leptin Signaling
100%
Leptin Antagonist
60%
Hepatic Stellate Cell Activation
40%
Thioacetamide
40%
Fibrosis Models
40%
Mortality Rate
20%
Therapeutic Modalities
20%
Serum Cholesterol
20%
Hepatic Fibrosis
20%
Serum Triglycerides
20%
Improved Survival
20%
Liver Disease
20%
Interferon-α (IFN-α)
20%
α-smooth muscle Actin (α-SMA)
20%
Muscle Activation
20%
Hepatic Stellate Cells
20%
Change in Weight
20%
Profibrotic
20%
Steatohepatitis
20%
Procollagen
20%
Antifibrotic
20%
Progressive Liver Fibrosis
20%
T Cell Polarization
20%
Medicine and Dentistry
Liver Fibrosis
100%
Cell Function
100%
Competitive Inhibition
100%
Leptin
100%
Stellate Cell
100%
Hepatic Stellate Cell
27%
Fibrosis
18%
In Vitro
18%
Thioacetamide
18%
Therapeutic Modality
9%
Mortality Rate
9%
Triacylglycerol
9%
Liver Disease
9%
Promoter Region
9%
Interferon
9%
T Cell
9%
Smooth Muscle Actin
9%
Ob/Ob Mouse
9%
Procollagen
9%
Steatohepatitis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
100%
Leptin
100%
Fibrosis
18%
Thioacetamide
18%
Mortality Rate
9%
Triacylglycerol
9%
Interferon
9%
Ob/Ob Mouse
9%
Smooth Muscle Actin
9%
Procollagen
9%
Liver Disease
9%